Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific pricing, demand in India & quality. “India is not a ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...

Industry leaders share their 2026 tech predictions, covering AI at scale, cloud autonomy, security risk, observability, ...

Thorndike Development is examining how expectations for home builders in Massachusetts have shifted as buyers weigh rising costs, changing lifestyles, and long-term plans for work and retirement.

The adoption of biosimilars is increasing, with a predicted global market CAGR of 18%, though uptake varies by market and is influenced by factors like rebate schemes and patent litigation.

Mark Cuban Cost Plus Drug is coming to TrumpRx, the federal initiative to offer Americans lower-cost prescriptions by buying ...

Long-time Republican U.S. Sen. Lindsey Graham is only leading by two points in a matchup against a generic Democrat.

GE Vernova Hitachi's BWRX-300 small modular reactor is suitable for construction in the UK, regulators have concluded ...

And now it's my pleasure to host this session with BrightSpring. They're one of the largest diversified home care providers in the U.S. And today with us in 1 room is Jon Rousseau, President and CEO; ...

Formularies continue to increase in complexity, and changes to those formularies are especially challenging for consumers to navigate.